Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
NMDA receptor antibodies associated with distinct white matter syndromes.
Intestinal Microbiota as Modulators of the Immune System and Neuroimmune System: Impact on the Host Health and Homeostasis.
Natalizumab and monocytes in multiple sclerosis: The dim haze of mystery and the enchantment of pursuit.
[Does interferon beta slow the progression of multiple sclerosis? - Long-term effect of IFN-β on progression of physical disability is still not proven].
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Microcystic macular oedema confirmed, but not specific for multiple sclerosis.
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.
Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis.
Serum uric acid level in patients with relapsing-remitting multiple sclerosis.
Ambulation and multiple sclerosis.
Standardized magnetic resonance imaging acquisition and reporting in pediatric multiple sclerosis.
Self-reported use of the upper limbs related to clinical tests in persons with multiple sclerosis.
Serum and cerebrospinal fluid heavy neurofilaments and antibodies against them in early multiple sclerosis.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Bilateral optic neuritis after inactivated influenza vaccination.
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation.
Color vision versus pattern visual evoked potentials in the assessment of subclinical optic pathway involvement in multiple sclerosis.
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.]
Managed care aspects of managing multiple sclerosis.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
Retrieval practice is a robust memory aid for memory-impaired patients with MS.
Quantitative assessment of finger motor impairment in multiple sclerosis.
Pages
« first
‹ previous
…
421
422
423
424
425
426
427
428
429
…
next ›
last »